|
|
||||||||
Original Research Communication |
1 From the Department of Pharmacology and the Locus for Homocysteine and Related Vitamins, University of Bergen, Norway; Axis-Shield ASA, Oslo; and the Diabetes Unit, King Edward Memorial Hospital and Research Centre, Pune, India.
2 Supported by the EU Commission Demonstration Project (contract no. BMH4-98-3549) and The Advanced Research Programme and the Programme for Advanced Technical Equipment of the Norwegian Research Council.
3 Address reprint requests to H Refsum, Department of Pharmacology, University of Bergen, Armauer Hansens Hus, 5021 Bergen, Norway. E-mail: helga.refsum{at}farm.uib.no.
See corresponding editorial on page 157.
| ABSTRACT |
|---|
|
|
|---|
Objective: The objective was to examine indicators of cobalamin status in Asian Indians.
Design: The study population included 204 men and women aged 2755 y from Pune, Maharashtra, India, categorized into 4 groups: patients with cardiovascular disease (CVD) and diabetes, patients with CVD but no diabetes, patients with diabetes but no CVD, and healthy subjects. Data on medical history, lifestyle, and diet were obtained by interviews and questionnaires. Blood samples were collected for measurement of serum or plasma total cobalamin, holotranscobalamin (holoTC), methylmalonic acid (MMA), and total homocysteine (tHcy) and hemetologic indexes.
Results: MMA, tHcy, total cobalamin, and holoTC did not differ significantly among the 4 groups; therefore, the data were pooled. Total cobalamin showed a strong inverse correlation with tHcy (r = -0.59) and MMA (r = -0.54). Forty-seven percent of the subjects had cobalamin deficiency (total cobalamin <150 pmol/L), 73% had low holoTC (<35 pmol/L), 77% had hyperhomocysteinemia (tHcy >15 µmol/L), and 73% had elevated serum MMA (>0.26 µmol/L). These indicators of impaired cobalamin status were observed in both vegetarians and nonvegetarians. Folate deficiency was rare and only 2.5% of the subjects were homozygous for the MTHFR 677C
T polymorphism.
Conclusions: About 75% of the subjects had metabolic signs of cobalamin deficiency, which was only partly explained by the vegetarian diet. If impaired cobalamin status is confirmed in other parts of India, it may have important health implications.
Key Words: Ethnicity diet blood cobalamin deficiency holotranscobalamin homocysteine folate methylmalonic acid methylenetetrahydrofolate reductase MTHFR polymorphism methionine synthase reductase MTRR polymorphism vegetarian diet India
| INTRODUCTION |
|---|
|
|
|---|
Symptomatic cobalamin deficiency in white vegetarians is believed to be rare (5). Most whites begin consuming a vegetarian diet early in adult life when they have adequate stores of cobalamin and normal gastrointestinal function. Under these conditions, it may take decades to develop an overt deficiency (5). In contrast, most vegetarians in India begin consuming a vegetarian diet as infants and thus have life-long low cobalamin intakes. Malnutrition is common in India (6) and tropical sprue, gastrointestinal infections, and other nutrient deficiencies frequently result in a malabsorptive state (7, 8); therefore, one would expect a high prevalence of cobalamin deficiency in India. Indeed, reports from both India (9, 10) and studies of Indians living in other countries (11, 12) suggest that nutritional cobalamin deficiency is common. Still, the number of reports on cobalamin status in Asian Indians is surprisingly sparse.
Classic cobalamin deficiency is associated with megaloblastic anemia and neurologic symptoms (13). The typical hematologic changes associated with cobalamin deficiency are easy to detect, but they develop at a late stage of the condition (8) and may even be absent (14). Measurement of serum cobalamin is the most commonly used biochemical test for diagnosing cobalamin deficiency, but it lacks sensitivity (15). A newer approach is to determine the amount of cobalamin bound to transcobalamin (holotranscobalamin; holoTC), ie, the fraction of serum cobalamin that becomes internalized by the cells (5, 16). Studies in the past 15 y established that markers of cobalamin function, particularly total homocysteine (tHcy) and methylmalonic acid (MMA), become elevated in subtle cobalamin deficiency states not characterized by the typical clinical symptoms (14). Recently, it was reported that plasma tHcy concentrations are higher in vegans than in omnivores (17). A similar finding of elevated tHcy and MMA was observed in infants in a macrobiotic (vegan) community (18). In the current study we report the cobalamin status of 204 subjects from the state of Maharashtra in India, nearly 40% of whom adhered to a vegetarian diet.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Blood samples were collected
2 wk after all minor illnesses were treated successfully. Exclusion criteria for all subjects were acute or severe illness or treatment with nitrous oxide anesthesia during the previous 3 mo, evidence of large vessel disease other than atherosclerosis, pregnancy, or excessive alcohol consumption. The study was approved by the Ethical Committee of the KEM Hospital and Research Centre. Informed consent was obtained from all subjects.
Data collection
Questionnaires were completed by a research assistant. Information on the subjects' personal and family histories of CVD, smoking habits, and intakes of vitamin supplements, drugs, and alcohol were collected. In India, most of the animal-derived food protein consumed is derived from dairy products, eggs, chicken and other poultry, mutton, and fish. For each of these food groups, the frequency of intake was reported in terms of 6 categories (never,
1 time/y,
1 time/mo,
1 time/wk, 25 times/wk, and almost daily). Height, weight, waist and hip circumferences, pulse rate, and blood pressure were measured. Pulse rate and blood pressure measurements were repeated twice and the means of the 2 measurements were calculated. All subjects underwent a stress test on a treadmill during which an electrocardiogram was produced.
Blood sampling and biochemical methods
A fasting blood sample was collected from all subjects. Whole blood was collected into tubes without anticoagulant (for preparation of serum) or into tubes containing the anticoagulant EDTA. The serum fraction was obtained by centrifugation (1300 x g, 20 min, 4°C) after storing the whole blood at room temperature for
1 h. The EDTA-containing tubes were immediately placed on ice and centrifuged (1300 x g, 20 min, 4°C) within 30 min; plasma was collected and stored at -20°C.
Plasma tHcy was analyzed by using a fully automated HPLC method with fluorescence detection (19). The between-day CV was <5% (19). MMA in serum was determined by capillary electrophoresis with laser-induced fluorescence detection (20). The concentrations of both tHcy and MMA were later confirmed by gas chromatographymass spectrometry (GC-MS) based on ethylchloroformate derivatization (21). Serum concentrations of folate and cobalamin were determined by using microbiological assays (22, 23). The folate and cobalamin assays were both adapted to a microtiter plate format and carried out by a robotic workstation (Microlab AT plus 2; Hamilton Bonaduz AG, Bonaduz, Switzerland). Plasma holoTC was measured directly by using a novel radioimmunoassay (HoloTC RIA kit; Axis-Shield ASA, Oslo). The assay is based on monoclonal antibodies against transcobalamin. Briefly, plasma (0.4 mL) was diluted 2-fold with 0.1 mol phosphate-buffered saline/L, after which the monoclonal antibody attached to magnetic beads was added. After incubation for 1 h on a roller mixer, the holoTC attached to the beads was precipitated by using a magnetic rack and the supernatant fluid was discarded. The beads were washed once with phosphate-buffered saline. Thereafter, a radioisotope dilution assay using intrinsic factor as binder was performed. The CV of the assay was <8% and the lower limit of detection was
5 pmol/L.
Creatinine and the hematologic indexes were determined in the routine clinical chemistry laboratory at the KEM Hospital. Genotyping was carried out by using EDTA-containing blood or serum. To determine the presence of a C-to-T substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase (MTHFR 677C
T polymorphism), polymerase-chain-reaction (PCR) products were analyzed by using a multiple-injection capillary electrophoresis technique as previously described (24). A real-time PCR assay was used to determine the presence of an A-to-G substitution at nucleotide 66 of the gene for 5-methyltetrahydrofolatehomocysteine methyltransferase reductase (MTRR 66A
G polymorphism) (25).
Description of variables
Several continuous variables were categorized: cobalamin deficiency was defined as a serum cobalamin concentration <150 pmol/L, low holoTC was defined as concentration <35 pmol/L (16), folate deficiency was defined as a serum folate concentration <5 nmol/L, elevated serum MMA was defined as a concentration >0.26 µmol/L, and hyperhomocysteinemia was defined as a tHcy concentration >15.0 µmol/L. In the logistic regression analyses, elevated tHcy and MMA concentrations were used as outcome variables; a tHcy concentration of 20.0 µmol/L and an MMA concentration of 0.50 µmol/L were used as thresholds. Thrombocytopenia was defined as a platelet count <140 x 109/L, macrocytosis as a mean corpuscular volume >100 fL, and anemia as a hemoglobin concentration <135 g/L for men and <115 g/L for women. Age was divided into the following categories:
40, 4145, 4650, and >50 y. A subject was considered a vegetarian (n = 78) only if he or she never ate mutton, poultry, fish, or eggs; all other subjects were categorized as nonvegetarians (n = 126). In the logistic regression analyses, the frequency of intake of mutton, poultry, eggs, and fish was divided into 2 groups (
1 time/mo and >1 time/mo).
Statistical analyses
Results are presented as medians, percentages, and 5th and 95th percentiles unless otherwise indicated. Student's t test for independent samples, one-way analysis of variance, and the chi-square test were used for comparisons between groups. When significant differences among the means were observed, Tukey's post hoc test was performed to identify significantly different group means. The distributions of the platelet count and of blood concentrations of tHcy, MMA, and vitamins were markedly skewed, and log transformed values were used in the statistical analyses.
Determinants of cobalamin status were identified by Spearman rank-order correlation coefficients, and analysis of variance was used to assess the relation between the various determinants and cobalamin concentrations. Odds ratios (ORs) for tHcy concentrations >20 µmol/L, for MMA concentrations >0.50 µmol/L, or for cobalamin deficiency were obtained by logistic regression analyses. We also performed a logistic regression analysis of the risk of cobalamin deficiency in subjects with infrequent intake (
1 time/mo) for the various food groups. Subjects who had a frequency of intake >1 time/mo were used as a reference. The independent variables were entered in the model as indicator variables. All relevant associations were tested for linear trend.
A P value <0.05 (two sided) was considered significant. SPSS version 10 for Macintosh (SPSS Inc, Chicago) was used for the statistical analyses. The graph depicting the relation between cobalamin and abnormal tHcy, MMA, and holoTC concentrations was constructed by using the supsmu scatterplot smoother of S-PLUS 2000 (Windows NT version, 1999; MathSoft, Inc, Seattle).
| RESULTS |
|---|
|
|
|---|
T polymorphism, and serum concentrations of cobalamin, holoTC, MMA, and creatinine did not differ significantly among the groups. Thus, to increase the power of the statistical analyses, the data from all 4 groups were pooled.
|
Median total cobalamin and holoTC concentrations were low; the corresponding means ± SDs were 205 ± 225 µmol/L and 35 ± 44 pmol/L, respectively. Nearly 50% of the subjects had cobalamin deficiency and an even higher proportion (73%) had low holoTC concentrations. In contrast, serum folate concentrations were relatively high (median: 12.2 nmol/L) and only 5% of the subjects were folate deficient. Plasma tHcy was markedly elevated in 77% of the total population, with a median of nearly 20 µmol/L ( ± SD: 23.2 ± 13.1 µmol/L). About 3 of 4 subjects had a tHcy concentration >15 µmol/L and only 6% had a tHcy concentration <10 µmol/L. Serum MMA was also markedly elevated, with a median of 0.49 µmol/L ( ± SD: 0.60 ± 0.60 µmol/L); 73% of the population had a concentration above the normal upper limit of 0.26 µmol/L.
The prevalence of the MTHFR TT genotype in the total population was only 2.5%, which corresponds to a T allele frequency of 12.5%. This value was markedly lower than the prevalence observed in whites and most other Asian populations (T allele frequency of
40%) (26, 27). We also determined the MTRR 66A
G polymorphism, and found an allele frequency of 45%, which is nonsignificantly lower than that reported in a Canadian study (25). The genotype distributions of both polymorphisms were compatible with Hardy-Weinberg equilibrium.
Variables associated with cobalamin, holoTC, tHcy, and MMA
Total cobalamin, holoTC, tHcy, and MMA concentrations were not significantly associated with age (data not shown). Concentrations of tHcy, cobalamin, and holoTC did not differ significantly between the sexes (data not shown), whereas MMA was higher in men than in women (0.52 compared with 0.29 µmol/L, P < 0.01).
The hemoglobin concentration, mean corpuscular volume, and prevalence of anemia or macrocytosis were not significantly associated with cobalamin concentrations (Table 2
). Red and white blood cell counts were also not significantly associated with cobalamin concentrations (data not shown). On the other hand, the platelet count was inversely correlated with MMA and tHcy. Thrombocytopenia was observed in 34% of subjects with a total cobalamin concentration <200 pmol/L but in only 8% of subjects with a total cobalamin concentration
200 pmol/L (P < 0.05; Table 3
).
|
|
|
200 pmol/L, of folate
12 nmol/L, and of creatinine
70 µmol/L (n = 16), MMA and tHcy concentrations remained elevated in 38% and 63% of the subjects, respectively.
|
|
Of the nonvegetarians, 22 ate animal-derived products rarely, ie, eggs, mutton, poultry, or fish <1 time/mo. Fifty-six subjects reported that they consumed at least one of these food groups between 1 time/wk and 1 time/mo. Forty-eight subjects ate one of these food groups >1 time/mo; of these subjects, 28 ate eggs, mutton, and poultry
2 times/wk. There was a strong correlation between the frequency of intake of each of the 4 food groups, from 0.76 (mutton versus fish) to 0.88 (mutton versus poultry).
The vitamin status and hematologic indexes of the vegetarians and nonvegetarians are shown in Table 5
. Hemoglobin concentrations were somewhat lower and the prevalence of macrocytosis was higher in the vegetarians than in the nonvegetarians; however, the differences, although statistically significant, were not pronounced. Significantly more vegetarians were cobalamin deficient; however, neither the concentrations of cobalamin, tHcy, and MMA nor the prevalence of hyperhomocysteinemia and elevated MMA concentrations differed significantly between the 2 groups. Of the subjects who reported consuming eggs, mutton, and poultry >2 times/wk (n = 28), 36% had cobalamin deficiency, 61% had elevated MMA concentrations, and 79% had hyperhomocysteinemia.
|
The risk of cobalamin deficiency, adjusted for age, sex, and disease category, was significantly increased in subjects who rarely consumed mutton (OR: 2.93; 95% CI: 1.58, 5.41), eggs (OR: 1.91; 1.06, 3.45), or poultry (OR: 2.24; 1.22, 4.10). Low fish intake was not significantly associated with cobalamin deficiency (OR: 1.55; 0.86, 2.81). In a model including frequencies of fish, poultry, mutton, and egg intakes, only an infrequent intake of mutton remained significantly associated with cobalamin deficiency (OR: 8.36; 1.64, 42.61). Repeating the analyses in only nonvegetarians did not materially alter the results.
| DISCUSSION |
|---|
|
|
|---|
5%) had low serum folate concentrations; of these, 8 had low cobalamin concentrations, high MMA concentrations, or both, which suggests that folate deficiency may be secondary to impaired cobalamin function (8). The biochemical and metabolic findings of cobalamin deficiency were observed in young and middle-aged adults of both sexes. Repeating the analyses separately in the 4 groups with or without diabetes or CVD did not alter the main finding, ie, that most subjects had cobalamin deficiency on the basis of low serum cobalamin concentrations concomitant with high tHcy and MMA concentrations.
A critical question is whether sampling conditions or analytic errors influenced the results. High concentrations of both tHcy and MMA were found with 2 different techniquestHcy with HPLC (19) and GC-MS (21) and MMA with capillary electrophoresis (20) and GC-MS (21). In the assay for tHcy, we also measured total cysteine. We found a mean cysteine concentration of 243 µmol/L, which is slightly lower than the mean concentration reported in Norwegians (28). Thus, the high tHcy concentrations were not due to analytic errors or to lyophilization of the samples. Moreover, concentrations of both serum cobalamin and holoTC were very low, whereas serum folate concentrations were normal relative to other populations. Finally, serum cobalamin was strongly correlated with both tHcy and MMA concentrations, which is consistent with findings in other cobalamin-deficient populations (29, 30).
One may ask whether the subjects investigated (residents of Pune, Maharashtra) represent the entire Indian population. Data from the Indian subcontinent suggest that cobalamin deficiency is common in healthy subjects (9, 31) and very common in malnourished children (10). Cobalamin deficiency is frequently observed in subjects with anemia (9) and it causes most of the cases of megaloblastic anemia (10, 32). Indian emigrants often have serum cobalamin concentrations that are lower than those of the population in the country of residence, but they rarely have cobalamin deficiency (33, 34). Only a few studies of tHcy concentrations in Indians have been published. In one study, CVD patients from Cochin, India, had tHcy concentrations of
10 µmol/L (35). In a recent study in Hyderabad, India, patients with coronary artery disease had tHcy concentrations similar to the values observed in the current study (36). In Indians living in Singapore (34), mean tHcy concentrations were 16.2 µmol/L in men and 11.5 µmol/L in women. In Indians living in the United Kingdom, the mean tHcy concentration was 10.8 µmol/L; this concentration was only marginally higher than the concentration observed in the white population of the United Kingdom (33). Thus, it seems that cobalamin deficiency and hyperhomocysteinemia are common in Indians, but that cobalamin concentrations are markedly influenced by age, sex, diet, and the site of residence, and probably by socioeconomic class.
Severe cobalamin deficiency can occur without the classic signs of anemia or macrocytosis (14). Unexpectedly, anemia was rare in the current study population, even among those with very low cobalamin concentrations concomitant with markedly elevated tHcy and MMA concentrations. A similar observation was made in other Indian populations (31, 37) and recently in pregnant Nepali women (38). One possible reason may be that an adequate folate intake protects against anemia and thereby masks the effect of cobalamin deficiency (13). The fact that even severe biochemical cobalamin deficiency is usually not accompanied by anemia in some Asian populations may explain why there are relatively few articles on cobalamin deficiency in a nation so dominated by vegetarianism.
Interestingly, we observed in our subjects that a low cobalamin concentration was often accompanied by thrombocytopenia. A low platelet count is frequently observed in severe cobalamin deficiency (14, 32), but it is usually believed to arise after the development of anemia (32). Hence, the reason for the thrombocytopenia in our subjects is unclear. It may have been related to impaired cobalamin function or to a lack of other nutrients. Recently, a study showed that vegans with normal cobalamin, tHcy, and hemoglobin concentrations had significantly lower leukocyte and platelet counts than did nonvegetarians (39), possibly because the vegans had protein or energy intakes that were lower than those of the nonvegetarians.
Although the risk of cobalamin deficiency was related to the frequency of intake of animal-derived foods, the low cobalamin status in the current study population was only partly explained by the population's vegetarian diet. Cobalamin deficiency was common, even in subjects who reported intakes of eggs, poultry, and mutton >2 times/wk (36%). Marked ethnic differences in cobalamin metabolism have been reported (40); therefore, the possibility that Indians have adapted to a chronic low cobalamin concentrations through genetic mechanisms should be considered. For example, the MTHFR 677C
T polymorphism is thought to protect against megaloblastic anemia by retaining cellular folates (41). However, the prevalence of the TT genotype in Indians was very low, much lower than in other Asian countries and comparable with that in Africa (26, 27).
Other than a vegetarian diet, the cause of cobalamin deficiency in the subjects in the current study was not clear. Tropical sprue, giardiasis, and other gastrointestinal infections are common in India (7), and these may lead to malabsorptive states and cobalamin deficiency (8). Interestingly, Lindenbaum et al (15) reported elevated tHcy and MMA concentrations in 3 patients with tropical sprue, 1 of whom had a normal cobalamin concentration (15). This finding agrees with our observation that even subjects with relatively high cobalamin concentrations can have high tHcy and MMA concentrations. Notably, in the study by Lindenbaum et al, the high MMA concentration was related to anaerobic gut flora and the high tHcy concentration was explained by a low cobalamin concentration.
Some studies suggest that overgrowth of intestinal bacterial may lead to formation and absorption of inactive cobalamin analogues (42, 43). In the current study, we first measured total cobalamin concentrations. To exclude the possibility that the measured cobalamin concentrations did not reflect the circulating cobalamin concentrations available to the mammalian cell, we measured holoTC concentrations. We observed a strong association between holoTC and total cobalamin concentrations. However, the holoTC concentrations measured did not explain the high MMA or tHcy concentrations in subjects with normal total cobalamin concentrations. These findings suggest an unusual regulation or function of cobalamin metabolism in this Indian population.
Megaloblastic anemia and neurologic symptoms occur late in the development of overt cobalamin deficiency (13). Perhaps more important from a general health perspective are the long-term effects of mild, subclinical cobalamin deficiency. Notably, elevated tHcy concentrations, low cobalamin concentrations, or both are related to CVD (44), cancer (45), cognitive impairment (46), delayed mental development in infancy and childhood (47, 48), and birth defects and pregnancy complications (49). A possible relation between impaired cobalamin status and childhood infections, tuberculosis, HIV infection, and reduced cellular immunity (5053) has also been implicated.
The population of the Indian subcontinent is >1 billion, most of whom consume a diet low in cobalamin. Isolated reports suggest that cobalamin deficiency in India is common; however, this problem has received little attention. The national strategies for improving micronutrient intake do not include cobalamin (54), and a search of MEDLINE (National Institutes of Health, Bethesda, MD) indicated that vitamin A, iron, zinc, and iodine are considered the micronutrients of interest by the Indian medical community. Our data from the city of Pune show that
75% of an adult population have metabolic evidence of cobalamin deficiency. If these findings are confirmed in other parts of India, this may have important health implications.
| ACKNOWLEDGMENTS |
|---|
rke Monsen for measurement of folate and cobalamin; and to Ingrid Alfheim and Åse-Lill Helgesen for measurement of holoTC. We greatly appreciate the technical assistance of E Blomdal and G Kvalheim. The authors made the following contributions to the study: H Refsum (principal investigator in Norway) participated in the concept and design of the study, participated in the analysis and interpretation of the data, and was responsible for drafting the article; CS Yajnik (principal investigator in India) and M Gadkari participated in the concept and design of the study, in the analysis and interpretation of the data, in the recruitment of the patients, and in the revision of the article; J Schneede provided data on MMA concentrations and participated in the analysis and interpretation of the data and in the revision of the article; SE Vollset participated in the design of the study, in the statistical analyses, in the analysis and interpretation of the data, and in the revision of the article; L Örning provided data on holoTC concentrations and participated in the analysis and interpretation of the data and in the revision of the article; AB Guttormsen provided data on tHcy and MMA concentrations and participated in the analysis and interpretation of data and in the revision of the article; A Joglekar and MG Sayyad participated in the recruitment of the patients, in the analysis and interpretation of the data, and in the revision of the article; A Ulvik provided data on the MTHFR and MTRR gene polymorphisms and participated in the interpretation of the data and in the revision of the article; and PM Ueland participated in the design, analysis, and interpretation of the data and in the draft and revision of the manuscript.
| REFERENCES |
|---|
|
|
|---|
T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost 1998;79:11921.[Medline]
This article has been cited by other articles:
![]() |
E. Villamor, M. Mora-Plazas, Y. Forero, S. Lopez-Arana, and A. Baylin Vitamin B-12 Status Is Associated with Socioeconomic Level and Adherence to an Animal Food Dietary Pattern in Colombian School Children J. Nutr., July 1, 2008; 138(7): 1391 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Gibson, Y. Abebe, S. Stabler, R. H. Allen, J. E. Westcott, B. J. Stoecker, N. F. Krebs, and K. M. Hambidge Zinc, Gravida, Infection, and Iron, but Not Vitamin B-12 or Folate Status, Predict Hemoglobin during Pregnancy in Southern Ethiopia J. Nutr., March 1, 2008; 138(3): 581 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Taneja, N. Bhandari, T. A Strand, H. Sommerfelt, H. Refsum, P. M Ueland, J. Schneede, R. Bahl, and M. K. Bhan Cobalamin and folate status in infants and young children in a low-to-middle income community in India Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1302 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hao, J. Ma, J. Zhu, M. J. Stampfer, Y. Tian, W. C. Willett, and Z. Li Vitamin B-12 Deficiency Is Prevalent in 35- to 64-Year-Old Chinese Adults J. Nutr., May 1, 2007; 137(5): 1278 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Narayanasamy, B. Subramaniam, C. Karunakaran, P. Ranganathan, R. Sivaramakrishnan, T. Sharma, V. S. Badrinath, and J. Roy Hyperhomocysteinemia and Low Methionine Stress Are Risk Factors for Central Retinal Venous Occlusion in an Indian Population Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1441 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Akhtar Is Homocysteine a Risk Factor for Atherothrombotic Cardiovascular Disease? J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1370 - 1371. [Full Text] [PDF] |
||||
![]() |
E. D. McLean, L. H. Allen, C. G. Neumann, J. M. Peerson, J. H. Siekmann, S. P. Murphy, N. O. Bwibo, and M. W. Demment Low Plasma Vitamin B-12 in Kenyan School Children Is Highly Prevalent and Improved by Supplemental Animal Source Foods J. Nutr., March 1, 2007; 137(3): 676 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
A D. Smith Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12 Am. J. Clinical Nutrition, January 1, 2007; 85(1): 3 - 5. [Full Text] [PDF] |
||||
![]() |
V. Devalia Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay BMJ, August 19, 2006; 333(7564): 385 - 386. [Full Text] [PDF] |
||||
![]() |
A. J.M. de Craen, D. J. Stott, R. G.J. Westendorp, A. Khare, M. Lopez, J. Gogtay, E. P. Quinlivan, J. F. Gregory III, H. Refsum, A. D. Smith, et al. Homocysteine, B vitamins, and cardiovascular disease. N. Engl. J. Med., July 13, 2006; 355(2): 205 - 206. [Full Text] [PDF] |
||||
![]() |
M. V Gamble, H. Ahsan, X. Liu, P. Factor-Litvak, V. Ilievski, V. Slavkovich, F. Parvez, and J. H Graziano Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1372 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H Allen Multiple micronutrients in pregnancy and lactation: an overview Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1206S - 1212S. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Refsum, A. D. Smith, P. M. Ueland, E. Nexo, R. Clarke, J. McPartlin, C. Johnston, F. Engbaek, J. Schneede, C. McPartlin, et al. Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion Clin. Chem., January 1, 2004; 50(1): 3 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lloyd-Wright, A.-M. Hvas, J. Moller, T. A.B. Sanders, and E. Nexo Holotranscobalamin as an Indicator of Dietary Vitamin B12 Deficiency Clin. Chem., December 1, 2003; 49(12): 2076 - 2078. [Full Text] [PDF] |
||||
![]() |
S. P. Murphy and L. H. Allen Nutritional Importance of Animal Source Foods J. Nutr., November 1, 2003; 133(11): 3932S - 3935. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wolters, S. Hermann, and A. Hahn B vitamin status and concentrations of homocysteine and methylmalonic acid in elderly German women Am. J. Clinical Nutrition, October 1, 2003; 78(4): 765 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
|